Form D · Biotechnology
Georgiamune, Inc.
Gaithersburg, MD · CIK 0002148230
Offering snapshot reported Aug 17, 2026 · SEC filing
- Reported sold
- $92.7M Offering amount: $132M
- Investors reported
- 26 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Jul 16, 2026 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Aug 17, 2026 | Initial | $92,692,709 | No comparison | 26 | SEC filing |
Offering details
- Securities
- Equity, Other
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-594417
Series B Preferred Stock
Source: Form D, filed Aug 17, 2026. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No matching detailed fund disclosure was found in the latest imported ADV filings. This does not establish that the issuer has no adviser.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Amy Abernethy | Director |
| Paul Brown | Director |
| Samir N. Khleif | Director, Executive |
| Nancy Ondovik | Director |
| Sean Parker | Director |
| Fredrick Schaufeld | Director |
| Elena Viboch | Director |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
940 Clopper Road Suite 942
Gaithersburg, MD, 20878-1301
Phone: 706-831-4549
Gaithersburg, MD, 20878-1301
Phone: 706-831-4549